Upgrade

Mangoceuticals, Inc.

MGRX

Last
$0.40
Day
-7.5%
1y
-80.1%
5y
-99.3%
52w
-84.3%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1334d
EMA 21
0.44
EMA 50
0.44
EMA 200
0.67
20d high
-16.8%
5y high
-99.3%
5y range
0th
Website · 3 employees · United States

Positions held

Your positions

MGRX isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
9
Hold
watch
Signal
Neutral
Target
$0.52
Stop
$0.36
Stop distance
10.0%
Target vs last
+30.0%

Fundamentals

Market cap$9.33MEnterprise value$9.37MTrailing P/E—Forward P/E—
PEG—Price / book0.62Beta1.98Dividend yield0.00%
Revenue growth-59.1%Earnings growth—Gross margin54.4%Operating margin-15.0%
Profit margin0.0%ROE-95.1%ROA-47.0%Debt / equity0.02
Current ratio0.18Free cash flow$1.27MAnalyst recommendationnoneMean target—
52w high$2.7552w low$0.16

Quarterly

2026-Q22026-Q12025-Q42025-Q32025-Q22025-Q1
Revenue$0.1M$0.1M$0.1M$0.1M$0.2M—
Op margin-1502.5%-4606.8%-1579.5%-8953.5%-3134.0%—
Net income-$1.3M-$3.4M-$2.8M-$7.6M-$5.4M—
Gross margin64.3%42.7%50.3%60.4%53.5%—
Gross profit$0.0M$0.0M$0.0M$0.1M$0.1M—
Operating income-$1.0M-$3.1M-$1.5M-$7.5M-$5.3M—
  • Revenue +1% vs prior quarter ($0.1M vs $0.1M).
  • Gross margin 64.3% (was 42.7% prior quarter).
  • Operating margin expanded to -1502.5%.

Yearly (6y)

2025202420232022
Revenue$0.5M$0.6M$0.7M$0.0M
Op margin-4200.5%-1411.6%-1260.3%-22279.7%
Net income-$20.6M-$8.7M-$9.2M-$2.0M
Gross margin54.9%61.7%59.0%54.3%
Gross profit$0.3M$0.4M$0.4M$0.0M
Operating income-$19.2M-$8.7M-$9.2M-$2.0M
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

MGRX · daily+0.3% over 13 sessions
Close EMA21 EMA50 EMA200
0.360.400.440.490.532026-092026-092026-092026-092026-102026-102026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
-$8M-$6M-$4M-$2M$0M-8953%-4445%64%2025-Q22025-Q32025-Q42026-Q12026-Q2